Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Viervoudige toename van opnames op kinder-IC vanwege RSV-bronchiolitis
apr 2022 | Virale infecties